NARA Discovery
Article Details
← Back to Search Results
Journal Article

Neuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity

Ghadha Ibrahim Fouad; Sara A. M. El-Sayed; Mostafa Mabrouk; Kawkab A. Ahmed; Hanan H. Beherei
Neurotoxicity Research · Vol. 40, Issue 5 · pp. 1479-1498 · 2022

Abstract

Cisplatin (CIS) is a platinum-based chemotherapeutic drug that is widely used to treat cancer. However, its therapeutic efficiency is limited due to its potential to provoke neurotoxicity. Sulforaphane (SF) is a natural phytochemical that demonstrated several protective activities. Iron oxide nanoparticles (Fe 3 O 4 -NPs) could be used as drug carriers. This study aimed to explore the nanotoxic influence of SF-loaded within Fe 3 O 4 -NPs (N.SF), and to compare the neuroprotective potential of both N.SF and SF against CIS-induced neurotoxicity. N.SF or SF was administrated intranasally for 5 days before and 3 days after a single dose of CIS (12 mg/kg/week, i.p.) on the 6 th day. Neuromuscular coordination was assessed using hanging wire and tail-flick tests. Acetylcholinesterase (AChE) activities and markers of oxidative stress were measured in the brain. In addition, the brain iron (Fe) content was estimated. CIS significantly induced a significant increase in AChE activities and lipid peroxides, and a significant decrement in glutathione (GSH) and nitric oxide (NO) contents. CIS elicited impaired neuromuscular function and thermal hyperalgesia. CIS-induced brains displayed a significant reduction in Fe content. Histopathological examination of different brain regions supported the biochemical and behavioral results. Contradict, treatment of CIS-rats with either N.SF or SF significantly decreased AChE activity, mitigated oxidative stress, and ameliorated the behavioral outcome. The histopathological features supported our results. Collectively, N.SF demonstrated superior neuroprotective activities on the behavioral, biochemical, and histopathological (striatum and cerebral cortex) aspects. N.SF could be regarded as a promising “pre-clinical” neuroprotective agent. Furthermore, this study confirmed the safe toxicological profile of Fe 3 O 4 -NPs.

Bibliographic Information

JournalNeurotoxicity Research
PublisherSpringer
Publication Date2022-10-01
Publication Year2022
Volume40
Issue5
Pages1479-1498
Document TypeJournal Article
Print ISSN1029-8428
eISSN1476-3524
DOI10.1007/s12640-022-00555-x

Access Information

NARA Access Coverage1999-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12640
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.